Talphera Stock Investor Sentiment

TLPH Stock   0.64  0.02  3.23%   
Under 72 percent of all Talphera's traders are curious in acquiring. The analysis of overall sentiment of trading Talphera stock suggests that a large number of investors are confidant at this time. Talphera's investing sentiment shows overall attitude of investors towards Talphera.
  
over six months ago at finance.yahoo.com         
Non-Postoperative Acute Pain Treatment Market to Exhibit Enormous Growth During the Study Period Del...
Yahoo News
over six months ago at thelincolnianonline.com         
AcelRx Pharmaceuticals Earns Sell Rating from Analysts at StockNews.com
news
over six months ago at news.google.com         
Talphera Price Target Increased to 6.00 by Analysts at HC Wainwright - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
HC Wainwright Adjusts Talpheras Price Target to 6 From 5, Keeps Buy Rating - Marketscreener.com
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Postoperative Acute Pain Market to Grow Immensely at a CAGR of 7.9 percent During the Study Period D...
Yahoo News
over six months ago at news.google.com         
Talphera Announces 26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Mon...
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Talphera Announces 26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Mon...
Yahoo News
over six months ago at thelincolnianonline.com         
StockNews.com Initiates Coverage on AcelRx Pharmaceuticals
news
over six months ago at news.google.com         
TLPH Talphera Inc - Stock Price, Quote and News - CNBC
Google News at Macroaxis
over six months ago at news.google.com         
TLPH News Today Why did Talphera stock go up today - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
AcelRx becomes Talphera, adopting new name to reflect pain pivot - FiercePharma
Google News at Macroaxis
over six months ago at news.google.com         
AcelRx Pharmaceuticals transitions to Talphera with new Nasdaq symbol By Investing.com - Investing.c...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Talphera that are available to investors today. That information is available publicly through Talphera media outlets and privately through word of mouth or via Talphera internal channels. However, regardless of the origin, that massive amount of Talphera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Talphera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Talphera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Talphera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Talphera alpha.

Talphera Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
10/01/2024
2
Disposition of 1623 shares by Vincent Angotti of Talphera at 1.3 subject to Rule 16b-3
10/25/2024
3
Talphera Upgraded by Maxim Group to Strong-Buy Rating
11/12/2024
4
AcelRx Pharmaceuticals GAAP EPS of -0.13 beats by 0.07
11/13/2024
5
Talphera, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
6
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.7299 subject to Rule 16b-3
11/27/2024
7
Talphera CEO Vincent J. Angotti buys 3,649 in company stock
12/02/2024
8
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.6399 subject to Rule 16b-3
12/05/2024

Complementary Tools for Talphera Stock analysis

When running Talphera's price analysis, check to measure Talphera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talphera is operating at the current time. Most of Talphera's value examination focuses on studying past and present price action to predict the probability of Talphera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talphera's price. Additionally, you may evaluate how the addition of Talphera to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios